Long-Acting GLP-1 Receptor Agonism Ameliorates Sinoatrial Node Dysfunction by Attenuating Electrophysiological and Structural Remodeling
Background: Sinoatrial node dysfunction (SND) causes bradyarrhythmia, while pacemaker therapy does not reverse injury to the sinoatrial node (SAN). Long-acting GLP-1 receptor agonists (GLP-1RAs) raise heart rate, but whether they can repair an injured SAN in SND remains unknown. Methods: In streptozotocin-induced SND rats, we studied an acute phase (SND, GLP-1RA treatment, glycemic control, and…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.